Lung Cancer Screening with Low-Dose CT: What We Have Learned in Two Decades of ITALUNG and What Is Yet to Be Addressed

The ITALUNG trial started in 2004 and compared lung cancer (LC) and other-causes mortality in 55–69 years-aged smokers and ex-smokers who were randomized to four annual chest low-dose CT (LDCT) or usual care. ITALUNG showed a lower LC and cardiovascular mortality in the screened subjects after 13 ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Mascalchi, Mario, Picozzi, Giulia, Puliti, Donella, Diciotti, Stefano, Deliperi, Annalisa, Romei, Chiara, Falaschi, Fabio, Pistelli, Francesco, Grazzini, Michela, Vannucchi, Letizia, Bisanzi, Simonetta, Zappa, Marco, Gorini, Giuseppe, Carozzi, Francesca Maria, Carrozzi, Laura, Paci, Eugenio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340172/
https://www.ncbi.nlm.nih.gov/pubmed/37443590
http://dx.doi.org/10.3390/diagnostics13132197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340172/
https://www.ncbi.nlm.nih.gov/pubmed/37443590
http://dx.doi.org/10.3390/diagnostics13132197

Ejemplares similares